midodrine has been researched along with droxidopa in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, K; Kunimoto, M; Ohshima, F | 1 |
| Kato, H; Kurihara, J; Okubo, Y; Suzuki, S; Takata, Y | 1 |
| Fujisaki, K; Hattori, F; Hirakata, H; Iida, M; Kanai, H; Koga, Y; Nakamura, S | 1 |
| Chan, BP; Sharma, V | 1 |
| Ohkido, I; Takane, K; Tanabe, N; Tanno, Y; Yamamoto, I; Yokoo, T; Yokoyama, K | 1 |
| Biaggioni, I | 1 |
| Dietrich, E; Espay, AJ; Gelblum, J; Kuritzky, L; Payne, R | 1 |
| Brenner, M; Hale, GM; Valdes, J | 1 |
| Goodman, BP; Gupta, F | 1 |
| Claassen, D; Goodman, BP; Mehdirad, A | 1 |
| Claassen, D; Goodman, BP; Kremens, D; Lew, M | 1 |
| Claassen, D; Vernino, S | 1 |
| Martin, T; Patrick, K | 1 |
| Mar, PL; Raj, SR | 1 |
| Chen, JJ; Dashtipour, K; Han, Y; Hauser, RA; Portillo, I; Tang, J | 1 |
| Pechere-Bertschi, A; Roukain, A | 1 |
| Cheshire, WP | 1 |
| Cannom, DS | 1 |
| Muldowney, J; Olshansky, B | 1 |
| Kaufmann, H; Palma, JA | 1 |
| Farrell, J; Kim, MJ | 1 |
| Behrens, A; Bejjani, A; Murray, B; Shah, N; Zhang, Y | 1 |
9 review(s) available for midodrine and droxidopa
| Article | Year |
|---|---|
[Pain caused by ephaptic transmission occurring in the recovery phase of diabetic vascular mononeuropathy was effectively suppressed with L-threo-3,4-dihydroxyphenyl-serine].
Topics: Adrenergic alpha-Agonists; Baroreflex; Diabetic Neuropathies; Droxidopa; Humans; Leg; Male; Middle Aged; Midodrine; Muscle, Skeletal; Nociceptors; Pain; Sympathetic Nervous System; Synaptic Transmission; Vasoconstrictor Agents | 1998 |
New developments in the management of neurogenic orthostatic hypotension.
Topics: Accidental Falls; Activities of Daily Living; Adrenergic alpha-1 Receptor Agonists; Aged; Aged, 80 and over; Antiparkinson Agents; Autonomic Nervous System; Dose-Response Relationship, Drug; Droxidopa; Drug Administration Schedule; Frail Elderly; Humans; Hypotension, Orthostatic; Midodrine; Prevalence; Quality of Life; Risk Factors; Syncope; Treatment Outcome | 2014 |
Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Topics: Accidental Falls; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Disease Management; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Midodrine; Vasoconstrictor Agents | 2015 |
The Treatment of Primary Orthostatic Hypotension.
Topics: Adult; Atomoxetine Hydrochloride; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Droxidopa; Drug Interactions; Exercise Therapy; Humans; Hypotension, Orthostatic; Midodrine; Posture; Treatment Outcome | 2017 |
Orthostatic hypotension for the cardiologist.
Topics: Antiparkinson Agents; Cardiologists; Droxidopa; Humans; Hypotension, Orthostatic; Midodrine; Posture; Sympathomimetics; Tilt-Table Test | 2018 |
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
Topics: Antiparkinson Agents; Bayes Theorem; Blood Pressure; Droxidopa; Humans; Hypertension; Hypotension, Orthostatic; Midodrine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Standing Position; Supine Position; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Topics: Blood Pressure; Comorbidity; Droxidopa; Humans; Hypertension; Hypotension, Orthostatic; Midodrine | 2019 |
Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
Topics: Cardiovascular System; Droxidopa; Humans; Hypotension, Orthostatic; Midodrine; Sympathomimetics | 2020 |
Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.
Topics: Adrenergic alpha-1 Receptor Agonists; Antiparkinson Agents; Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Midodrine; Outcome Assessment, Health Care; Parkinson Disease; Synucleinopathies | 2020 |
1 trial(s) available for midodrine and droxidopa
| Article | Year |
|---|---|
Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension.
Topics: Adrenergic alpha-Agonists; Aged; Antiparkinson Agents; Cerebrovascular Circulation; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Midodrine; Renal Dialysis | 2007 |
12 other study(ies) available for midodrine and droxidopa
| Article | Year |
|---|---|
Effect of midodrine on chlorpromazine-induced orthostatic hypotension in rabbits: comparison with amezinium, etilefrine and droxidopa.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Antipsychotic Agents; Blood Pressure; Chlorpromazine; Dose-Response Relationship, Drug; Droxidopa; Drug Administration Routes; Drug Interactions; Duodenum; Etilefrine; Hypotension, Orthostatic; Male; Midodrine; Pentolinium Tartrate; Prazosin; Pyridazines; Rabbits; Sympathomimetics | 2000 |
Comment on "Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension" by Fujisaki et al.
Topics: Adrenergic alpha-Agonists; Antiparkinson Agents; Cerebrovascular Circulation; Droxidopa; Humans; Hypotension, Orthostatic; Midodrine; Renal Dialysis | 2007 |
Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient.
Topics: Aged; Baroreflex; Carotid Sinus; Cold Temperature; Dialysis Solutions; Dizziness; Droxidopa; Enteral Nutrition; Gastrostomy; Humans; Hypertension; Hypotension; Kidney Failure, Chronic; Male; Midodrine; Posture; Radiation Injuries; Radiotherapy; Reflex, Abnormal; Renal Dialysis; Sodium; Sympathetic Nervous System; Temperature; Tongue Neoplasms | 2014 |
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
Topics: Accidental Falls; Aged, 80 and over; Antiparkinson Agents; Droxidopa; Female; Humans; Hypotension, Orthostatic; Midodrine; Multiple System Atrophy; Syncope; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Topics: Aged; Antiparkinson Agents; Droxidopa; Female; Humans; Hypotension, Orthostatic; Midodrine; Parkinson Disease; Supine Position; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
Topics: Antiparkinson Agents; Droxidopa; Drug Therapy, Combination; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Middle Aged; Midodrine; Mineralocorticoids; Parkinson Disease; Vasoconstrictor Agents | 2017 |
Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.
Topics: Aged; Antiparkinson Agents; Diabetes Mellitus, Type 2; Droxidopa; Female; Humans; Hypotension, Orthostatic; Midodrine; Parkinson Disease; Polypharmacy; Vasoconstrictor Agents | 2017 |
Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.
Topics: Antiparkinson Agents; Blood Pressure; Droxidopa; Humans; Hypotension, Orthostatic; Midodrine; Systematic Reviews as Topic; Vasoconstrictor Agents | 2017 |
[Arterial hypotension: behind the scenes].
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Droxidopa; Humans; Hypotension; Hypotension, Orthostatic; Midodrine | 2018 |
Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
Topics: Accidental Falls; Central Nervous System Agents; Droxidopa; Drug Substitution; Female; Humans; Hypertension; Hypotension, Orthostatic; Middle Aged; Midodrine; Patient Care Management; Risk Adjustment; Supine Position; Syncope, Vasovagal; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Orthostatic Hypotension: A Practical Approach.
Topics: Accidental Falls; Adolescent; Adult; Aged; Blood Pressure; Chest Pain; Diabetes Mellitus; Diet; Dizziness; Droxidopa; Fludrocortisone; Heart Disease Risk Factors; Heart Rate; Humans; Hypotension, Orthostatic; Middle Aged; Midodrine; Quality of Life; Supine Position; Systole; Young Adult | 2022 |
Droxidopa in the Management of Hepatorenal Syndrome.
Topics: Droxidopa; Hepatorenal Syndrome; Humans; Male; Middle Aged; Midodrine; Norepinephrine; Octreotide | 2023 |